ProPhase Labs, Inc. (PRPH) - מזומנים למניה

ProPhase Labs, Inc. (PRPH) is implementing preventive digital systems for home health monitoring. The synergy between diagnostic centers and pharmaceutical distribution channels, coupled with strict FDA oversight, creates a significant barrier to entry. The company is currently pivoting its capacity toward genomics, which is temporarily inflating costs. Cash per share dynamics on the GURU.Markets service time chart show that 0.07 determines this parameter level.
פילוחים אנליטיים של חברת ProPhase Labs, Inc.

This parameter determines the amount of liquid capital per common share, calculated as the ratio of total cash to the total number of shares outstanding. By analyzing the cash per share metric, an investor assesses the issuer's financial stability and margin of safety. For ProPhase Labs, Inc. (PRPH), this reserve is critical for supporting the costly robotization of diagnostic systems, as laboratory automation requires significant capital expenditures to scale genetic research.